Search results for "End Stage Renal Disease"

showing 10 items of 31 documents

Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4

2010

Objective The objective was to assess the role of office and ambulatory blood pressure (BP) on the development of end-stage renal disease (ESRD) in nondiabetic chronic renal failure. Design and method Seventy-nine patients [mean age 57 (standard deviation 11) years, 47 men, BMI 28 (4), office BP 151 (25)/92 (14) mmHg, estimated glomerular filtration rate 28 (14) ml/min per 1.73 m3] were included. The causes of renal disease were nephrosclerosis (n = 33), glomerulonephritis (n = 19), interstitial (n = 12) and others (n = 15). The average follow-up was 44 months (range 9-72 months). The primary outcome was a composite of death, from any cause, or the development of ESRD that require initiatio…

Malemedicine.medical_specialtyAmbulatory blood pressurePhysiologymedicine.medical_treatmentRenal functionBlood Pressureurologic and male genital diseasesEnd stage renal diseaseInternal medicineInternal MedicinemedicineHumansRenal replacement therapyAgedbusiness.industryProportional hazards modelBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseCircadian RhythmSurgeryBlood pressureAmbulatoryDisease ProgressionCardiologyKidney Failure ChronicFemaleCardiology and Cardiovascular MedicinebusinessKidney diseaseJournal of Hypertension
researchProduct

A new machine learning approach for predicting the response to anemia treatment in a large cohort of End Stage Renal Disease patients undergoing dial…

2015

Chronic Kidney Disease (CKD) anemia is one of the main common comorbidities in patients undergoing End Stage Renal Disease (ESRD). Iron supplement and especially Erythropoiesis Stimulating Agents (ESA) have become the treatment of choice for that anemia. However, it is very complicated to find an adequate treatment for every patient in each particular situation since dosage guidelines are based on average behaviors, and thus, they do not take into account the particular response to those drugs by different patients, although that response may vary enormously from one patient to another and even for the same patient in different stages of the anemia. This work proposes an advance with respec…

Malemedicine.medical_specialtyAnemiamedicine.medical_treatmentPopulationHealth InformaticsIron supplementMachine learningcomputer.software_genreModels BiologicalEnd stage renal diseaseCohort StudiesMachine LearningRenal DialysismedicineHumansIntensive care medicineeducationDialysiseducation.field_of_studybusiness.industryAnemiamedicine.diseaseAnemia managementComputer Science ApplicationsLarge cohortKidney Failure ChronicFemaleArtificial intelligencebusinesscomputerKidney diseaseComputers in Biology and Medicine
researchProduct

Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy--a Spanish multicentre experience.

2006

Background. Timely referral, preparation and initiation of dialysis remain problematic issues. The purpose of this study is to analyse the effect of chronic renal disease care and education on the mode of dialysis start (planned vs non-planned) and on the modality of renal replacement therapy (RRT). Methods. A total of 1504 patients from 35 hospitals started RRT in 2003. Out-patient, scheduled initiation of dialysis with a permanent vascular or peritoneal access was considered planned. Results. About 46% of the patients started non-planned dialysis. Of all the patients, 75% had 3 months of nephrological follow-up, but nearly half were never educated on dialysis options. Haemodialysis (HD) o…

Malemedicine.medical_specialtyPediatricsReferralmedicine.medical_treatmentPeritoneal dialysisEnd stage renal diseasePatient Education as TopicRenal DialysismedicineDiabetes MellitusHumansRenal replacement therapyVascular DiseasesIntensive care medicineDialysisRetrospective StudiesTransplantationbusiness.industryRetrospective cohort studyMiddle Agedmedicine.diseaseNephrologyKidney Failure ChronicFemaleKidney Cortex NecrosisHemodialysisbusinessPeritoneal DialysisKidney diseaseNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Sexual dysfunction in dialytic patients. A prospective cross-sectional observational study in two hemodialysis centers

2020

Objectives: Incidence and prevalence of patients in dialytic therapy increased considerably in recent years. The onset of new issues, once overshadowed, linked to a lower quality of life like sexual dysfunction became increasingly common. The first study in this area, dating back to the 1970s, shows the high prevalence of sexual dysfunction among patients in dialytic therapy of both sexes. Later studies proved an association of sexual dysfunction with psyche disorders, anxiety, depression and lack of self-confidence. The aim of this study is to describe the incidence of male and female sexual main dysfunctions, the latter not least in literature, in patients in hemodialytic therapy. With th…

Malemedicine.medical_specialtyUrologymedia_common.quotation_subjectEnd-Stage Renal DiseasePopulation030232 urology & nephrologyErectile disorderOrgasmEnd stage renal disease03 medical and health sciences0302 clinical medicineErectile DysfunctionRenal DialysisSurveys and QuestionnairesInternal medicinePremature ejaculationmedicineHumansProspective StudiesFemale sexual dysfunctionseducationDialysis End-Stage Renal Disease Sexual male dysfunction Erectile disorder Premature ejaculation Female sexual dysfunctions International Index of Erectile Function Premature EjaculationAgedmedia_commoneducation.field_of_studyPremature ejaculation030219 obstetrics & reproductive medicinebusiness.industryIncidence (epidemiology)Middle Agedmedicine.diseaseSexual male dysfunctionDiseases of the genitourinary system. UrologyCross-Sectional StudiesSexual dysfunctionErectile dysfunctionQuality of LifeFemaleRC870-923medicine.symptombusinessDialysisKidney disease
researchProduct

CAPD + hemoperfusion once a week in the management of children with end-stage renal disease

1983

With hemoperfusion there is a sharp decline in the solute concentration of the blood compartment, but immediately after HP the concentration of these substances rises to the original level (post-Hp rebound). It may be inferred that the result would be better and the rebound phenomenon less marked if hemoperfusion could be combined with a continuous dialysis system such as CAPD. The study was performed in 3 children of our CAPD programm. All patients were dialysed with 5 daily exchange each of one liter. The patients underwent at 2-hours hemoperfusion with a charcoal column (Gambro Adsorba 150 c) once a week. The data obtained with this form of treatment are indicative for a: significant in…

Malemedicine.medical_specialtymedicine.medical_treatment030232 urology & nephrologyBiomedical EngineeringUrologyMedicine (miscellaneous)Bioengineering030204 cardiovascular system & hematologyEnd stage renal diseasePeritoneal dialysisBiomaterials03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePeritoneal Dialysis Continuous AmbulatoryHumansMedicinePlatelet activationChildIntensive care medicineDialysisCreatininebusiness.industryLiterGeneral MedicineHemoperfusionUric AcidHemoperfusionchemistryCreatinineKidney Failure ChronicUric acidFemalebusinessPeritoneal Dialysis
researchProduct

Changes in serum fetuin-A and inflammatory markers levels in end-stage renal disease (ESRD): effect of a single session haemodialysis.

2007

Background: The aim of the present study was to evaluate the effect of a single haemodialysis (HD) session on serum fetuin-A levels, considered a negative acute phase response marker; moreover, we evaluated the behaviour of fibrinogen and high sensitivity C-reactive protein (hsCRP) as acute phase response and chronic/subclinical inflammation markers, respectively, after a single HD session. Methods: Serum fetuin-A, albumin, hsCRP and fibrinogen were measured in 72 patients before and after a single HD session. Results: After a single HD session, we observed a significant increase in fibrinogen levels, while fetuin-A levels decreased (p<0.05). Also, hsCRP levels were significantly increased.…

Malemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryInflammationFibrinogenEnd stage renal diseaseRenal DialysisInternal medicinemedicineHumansAgedbusiness.industryBiochemistry (medical)Acute-phase proteinAlbuminGeneral MedicineMiddle Agedmedicine.diseaseFetuinEndocrinologyKidney Failure ChronicFemaleHemodialysisalpha-Fetoproteinsmedicine.symptomInflammation MediatorsbusinessKidney diseasemedicine.drugClinical chemistry and laboratory medicine
researchProduct

Incidence of chronic pain in patients with end-stage renal disease on dialysis

2005

Malemedicine.medical_specialtymedicine.medical_treatmentMEDLINEPainend-stage renal disease dialysisEnd stage renal diseaseText miningRenal DialysisInternal medicinemedicineHumansIn patientGeneral NursingDialysisAgedbusiness.industryIncidenceIncidence (epidemiology)Chronic painMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicineChronic diseaseChronic DiseaseKidney Failure ChronicFemaleNeurology (clinical)businesschronic pain
researchProduct

[Penile Flexiflate® Surgitek prosthesis explant and simultaneous three-component hydraulic Titan® Alpha 1 prosthesis implantation, with double incisi…

2010

Introduction and Objectives We treated a 45 years old patient, suffering from diabetes mellitus since childhood, with retinal, neurovascular and kidney complications. In 1988, for erectile dysfunction (ED) resistant to medical injective treatment, the patient underwent ligation of the dorsal vein of the penis without any result. In 1989 a Flexiflate® hydraulic prosthesis was implanted with resolution of ED. In 2005 the patient underwent simultaneous kidney and pancreas transplant with a trans-laparotomic approach for end stage renal disease and diabetes mellitus. In 2009, because of the Flexiflate® Surgitek malfunction, the patient underwent explantation of the Flexiflate® prosthesis and si…

Malemedicine.medical_specialtymedicine.medical_treatmentProsthesis ImplantationProsthesisEnd stage renal diseaseProsthesis ImplantationDiabetic NeuropathiesErectile DysfunctionLaparotomymedicineHumansDiabetic NephropathiesLigationDevice Removalbusiness.industryPenile prosthesisGeneral MedicineEquipment DesignMiddle AgedNeurovascular bundleKidney TransplantationSurgerymedicine.anatomical_structureDiabetes Mellitus Type 1Patient SatisfactionKidney Failure ChronicImplantPancreas TransplantationPenile ProsthesisbusinessPenisDiabetic AngiopathiesPenisUrologia
researchProduct

Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.

2009

Background Nephrogenic systemic fibrosis (NSF) affects some patients on dialysis after gadolinium contrast agent–enhanced magnetic resonance imaging. It is characterized by progressive skin fibrosis of the extremities, sometimes including the trunk and internal organs. Methods The clinical course of 10 patients with biopsy-proven NSF was analyzed retrospectively with regard to gadolinium exposition, disease onset, and progression of NSF with special emphasis on physical mobility and impact of different therapeutic approaches. Results Despite physiotherapy and different additional therapeutic approaches (eg, immunosuppression, ultraviolet A-1 phototherapy, or extracorporal photopheresis) all…

Nephrogenic Fibrosing DermopathyAdultmedicine.medical_specialtymedicine.medical_treatmentBiopsyGadoliniumDermatologyHydronephrosisNephrectomyEnd stage renal diseaseNephrogenic Fibrosing DermopathyPhotopheresisFibrosisRenal DialysismedicineHumansKidney transplantationDialysisbusiness.industrymedicine.diseaseMagnetic Resonance ImagingSurgeryNephrogenic systemic fibrosisDisease ProgressionFemalebusinessKidney diseaseJournal of the American Academy of Dermatology
researchProduct

A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of h…

2012

Background: Calciphylaxis is a potentially fatal complication of persistent secondary hyperparathyroidism; its cause is still not clear. Unfortunately there is no close relation in severity of clinical picture, serological and pathological alteration. For this reason the prognosis is difficult to establish. Administration of sodium thiosulphate may reduce the precipitation of calcium crystals and improve the general clinical conditions before surgical parathyroidectomy, which seems the only therapeutic approach able to reduce the mortality risk in these patients. Methods and Results: A 60 year old female patient suffering from End Renal Stage Disease, on haemodialysis from 2001 due to the o…

ParathyroidectomyGraft Rejectionmedicine.medical_specialtymedicine.medical_treatmentCalciphylaxiSettore MED/08 - Anatomia PatologicaGeneral Biochemistry Genetics and Molecular BiologyEnd stage renal diseaseFatal OutcomeSecondary hyperparathyroidism; Calciphylaxis; Kidney transplant; ParathyroidectomymedicineHumansKidney transplantDialysisParathyroidectomySettore MED/14 - NefrologiaCalciphylaxisHyperparathyroidismbusiness.industryCalciphylaxisMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSecondary hyperparathyroidismSettore MED/18 - Chirurgia GeneraleHemolytic-Uremic SyndromeKidney Failure ChronicSecondary hyperparathyroidismFemaleHyperparathyroidism SecondaryComplicationbusinessBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct